Reducing Disparities in Medication Adherence of Patients With Systemic Lupus Erythematosus (SLE)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 135
- 试验地点
- 2
- 主要终点
- Acceptability as Measured by Provider Survey
研究概览
简要总结
This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- All followup patients seen at the Duke Lupus clinic
排除标准
- •Patients not seen at the Duke Lupus Clinic
- •New patients seen for the first time at the Duke Lupus Clinic
- •Patients who are not prescribed any lupus medications
研究组 & 干预措施
Intervention arm
Lupus clinic providers will use Surescripts refill information to assess adherence level and address adherence barriers. We will assess the feasibility and acceptability of the intervention.
干预措施: Behavioral Intervention (Behavioral)
结局指标
主要结局
Acceptability as Measured by Provider Survey
时间窗: 12 weeks
Acceptability as measured by provider survey, score range 1-5, with a higher score indicating that the intervention was more acceptable.
Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence
时间窗: 12 weeks
Feasibility as measured by documentation of adherence assessment made by provider.
次要结局
- Percentage of Adherent Participants as Determined by Medication Possession Ratio (MPR)(Baseline, 12 weeks)
- Medication Adherence as Determined by Self Report(12 weeks)